Trial ID or NCT#

NCT00464620

Status

NOT RECRUITING

Purpose

This study will examine the response rate and the 6-month progression-free survival rates of subjects with advanced sarcoma treated with dasatinib.

Official Title

A Phase II Trial of Dasatinib in Advanced Sarcomas

Eligibility Criteria

Ages Eligible for Study: Older than 13 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Contact us to find out if this trial is right for you.

CONTACT

Cancer Clinical Trials Office
(650) 498-7061